TELA Bio, Inc. TELA

1.26 (0.01) (0.79%) as of 25 Sep
Market cap
$57.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
1,232.54% (616.62%) (223.35%) 1,654.21%

+8 more TTM periods

ROA
(64.71%) (54.15%) (46.23%) (68.06%)
ROIC
(217.11%) (189.96%) (189.70%) (166.17%)
Return on Tangible Assets
(107.46%) (81.93%) (64.90%) (94.46%)
Average Days of Receivables
44.02 43.88 47.05 53.40
Free Cash Flow per Share
(0.55) (0.53) (0.61) (0.69)
Free Cash Flow
(31.62) (30.20) (28.67) (31.50)
Capital Expenditures
(0.48) (0.53) (0.45) (0.62)
Piotroski F-Score
3.00 4.00 3.00 4.00
Other line items
Cash ROIC
(44.08%) (32.88%) (25.01%) (42.44%)
Accounts Receivable Turnover
7.66 7.97 7.85 6.85
Accounts Payable Turnover
10.96 6.61 11.47 10.25
Inventory Turnover
2.26 2.03 2.15 1.98
Average Days of Payables
41.53 54.49 32.98 34.83
Days of Inventory on Hand
159.29 170.89 157.35 169.64
Tax Rate
0.01 0.01 0.00 0.00
Research and Development Expense of Revenue
11.94% 11.17% 11.49% 11.84%
Selling, General and Administrative Expense of Revenue
98.43% 97.92% 98.26% 101.42%
Share Based Compensation of Revenue
4.00% 4.42% 4.73% 5.29%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
0.76 0.74 0.73 0.79
Depreciation/Fixed assets
0.49 0.47 0.45 0.47
Capex/Depreciation
(0.48) (0.53) (0.44) (0.59)
Revenue per Share
1.39 1.41 1.71 1.70
Operating CF per Share
(0.54) (0.52) (0.60) (0.68)
Capex per Share
(0.01) (0.01) (0.01) (0.01)
Capex to Sales
0.01 0.01 0.01 0.01
Net Profit Margin
(51.53%) (49.30%) (48.37%) (50.61%)

Fold the line items

Columns are period end dates